These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2971475)
1. Nonspecificity of a direct 17 alpha-hydroxyprogesterone radioimmunoassay kit when used with samples from neonates. Makela SK; Ellis G Clin Chem; 1988 Oct; 34(10):2070-5. PubMed ID: 2971475 [TBL] [Abstract][Full Text] [Related]
2. Serum 17 alpha-hydroxyprogesterone in infants and children as measured by a direct radioimmunoassay kit. Lee A; Ellis G Clin Biochem; 1991 Dec; 24(6):505-11. PubMed ID: 1773491 [TBL] [Abstract][Full Text] [Related]
3. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia. Mitchell ML; Hermos RJ Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565 [TBL] [Abstract][Full Text] [Related]
4. [Neonatal mass-screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. I. Microfilter paper methods for radioimmunoassay of 17 alpha-hydroxyprogesterone]. Shimozawa K Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1845-9. PubMed ID: 6609091 [TBL] [Abstract][Full Text] [Related]
5. Usefulness and limitations of an in-house direct radioimmunoassay for 17-hydroxyprogesterone in serum. Lo MS; Ng ML; Wu LL; Azmy BS; Khalid BA Malays J Pathol; 1996 Jun; 18(1):43-52. PubMed ID: 10879224 [TBL] [Abstract][Full Text] [Related]
6. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens. Thompson R; Seargeant L; Winter JS J Pediatr; 1989 Mar; 114(3):400-4. PubMed ID: 2784166 [TBL] [Abstract][Full Text] [Related]
7. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Wong T; Shackleton CH; Covey TR; Ellis G Clin Chem; 1992 Sep; 38(9):1830-7. PubMed ID: 1526021 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia. Robinson JA; Dyas J; Hughes IA; Riad-Fahmy D Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():58-65. PubMed ID: 3827186 [TBL] [Abstract][Full Text] [Related]
9. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy. Riordan FA; Wood PJ; Wakelin K; Betts P; Clayton BE Lancet; 1984 Mar; 1(8379):708-11. PubMed ID: 6143043 [TBL] [Abstract][Full Text] [Related]
10. Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots. Larsson A; Hagenfeldt L; von Döbeln U; Curstedt T; Gustafsson J; Svensson E Horm Res; 1988; 30(6):235-40. PubMed ID: 3250925 [TBL] [Abstract][Full Text] [Related]
11. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns. Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477 [TBL] [Abstract][Full Text] [Related]
12. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche. Granoff AB; Chasalow FI; Blethen SL J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895 [TBL] [Abstract][Full Text] [Related]
20. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia. Hubl W; Fehér T; Rohde W; Dörner G; Taubert H; Freymann E Endokrinologie; 1982 Jun; 79(2):165-72. PubMed ID: 6751805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]